Latest & greatest articles for constipation

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on constipation or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on constipation and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for constipation

161. Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials

Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2008 DARE.

162. Cost-effectiveness of macrogol 4000 compared to lactulose in the treatment of chronic functional constipation in the UK

Cost-effectiveness of macrogol 4000 compared to lactulose in the treatment of chronic functional constipation in the UK Cost-effectiveness of macrogol 4000 compared to lactulose in the treatment of chronic functional constipation in the UK Cost-effectiveness of macrogol 4000 compared to lactulose in the treatment of chronic functional constipation in the UK Guest J F, Clegg J P, Helter M T Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion (...) on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The objective was to examine the cost-effectiveness of macrogol 4000 compared with lactulose for the treatment of chronic functional constipation in adult patients. The authors concluded that macrogol 4000 was a cost-effective treatment from the perspective of the British National Health Service

2008 NHS Economic Evaluation Database.

163. Clinical trial: renzapride therapy for constipation-predominant irritable bowel syndrome--multicentre, randomized, placebo-controlled, double-blind study in primary healthcare setting (Abstract)

Clinical trial: renzapride therapy for constipation-predominant irritable bowel syndrome--multicentre, randomized, placebo-controlled, double-blind study in primary healthcare setting Relatively few pharmacological treatment options are available for treating patients with irritable bowel syndrome. New and effective medicines are urgently required.To identify an appropriate dosage of renzapride (a 5-HT(4) receptor full agonist/5-HT(3) receptor antagonist) to treat abdominal pain/discomfort (...) in patients with constipation-predominant irritable bowel syndrome.In this randomized, placebo-controlled, phase IIb study in the primary care setting, men and women were randomized to placebo or renzapride (1, 2 or 4 mg/day) for 12 weeks. The primary outcome measure was patient self-assessed relief of abdominal pain/discomfort during weeks 5-12. Secondary efficacy measures included patients' assessment of their bowel habits, stool consistency and quality of life.Although there were no statistically

2008 EvidenceUpdates Controlled trial quality: predicted high

164. Behavioral therapy for childhood constipation: a randomized, controlled trial Full Text available with Trip Pro

Behavioral therapy for childhood constipation: a randomized, controlled trial It has been suggested that the addition of behavioral interventions to laxative therapy improves continence in children with functional fecal incontinence associated with constipation. Our aim was to evaluate the clinical effectiveness of behavioral therapy with laxatives compared with conventional treatment in treating functional constipation in childhood.In this randomized, controlled trial conducted in a tertiary (...) hospital in The Netherlands, 134 children aged 4 to 18 years with functional constipation were randomly assigned to 22 weeks (12 visits) of either behavioral therapy or conventional treatment. Primary outcomes were defecation frequency, fecal incontinence frequency, and success rate. Success was defined as defecation frequency of > or = 3 times per week and fecal incontinence frequency of < or = 1 times per 2 weeks irrespective of laxative use. Secondary outcomes were stool-withholding behavior

2008 EvidenceUpdates Controlled trial quality: predicted high

165. Sacral nerve stimulation for faecal incontinence and constipation in adults. (Abstract)

Sacral nerve stimulation for faecal incontinence and constipation in adults. Faecal incontinence and constipation are disabling conditions that reduce quality of life. If conservative treatment fails, one option is sacral nerve stimulation (SNS), a minimally invasive technique allowing modulation of the nerves and muscles of the pelvic floor and hindgut.To assess the effects of SNS for faecal incontinence and constipation in adults.We searched the Cochrane Incontinence Group Specialised Trials (...) Register (searched 24 April 2007) and the reference lists of relevant articles.All randomised or quasi-randomised trials assessing the effects of SNS for faecal incontinence or constipation in adults.Two review authors independently screened the search results, assessed the methodological quality of the included studies, and undertook data extraction.Three crossover studies were included. Two, enrolling 34 (Leroi) and two participants (Vaizey), assessed the effects of SNS for faecal incontinence

2007 Cochrane

166. Methylnatrexone for opioid induced constipation in advanced illness and palliative care: horizon scanning technology briefing

Methylnatrexone for opioid induced constipation in advanced illness and palliative care: horizon scanning technology briefing Methylnatrexone for opioid induced constipation in advanced illness and palliative care: horizon scanning technology briefing Methylnatrexone for opioid induced constipation in advanced illness and palliative care: horizon scanning technology briefing National Horizon Scanning Centre Record Status This is a bibliographic record of a published health technology assessment (...) from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation National Horizon Scanning Centre. Methylnatrexone for opioid induced constipation in advanced illness and palliative care: horizon scanning technology briefing. Birmingham: National Horizon Scanning Centre (NHSC). 2007 Authors' objectives This study examines the use of Methylnatrexone for opioid induced constipation in advanced illness and palliative care. Project page URL Indexing

2007 Health Technology Assessment (HTA) Database.

167. Laxatives for the management of constipation in palliative care patients. (Abstract)

Laxatives for the management of constipation in palliative care patients. Constipation is a common problem for palliative care patients which can generate considerable suffering for patients due to both the unpleasant physical symptoms and psychological preoccupations that can arise. There is uncertainty about the 'best' management of constipation in palliative care patients and variation in practice between palliative care settings.To determine the effectiveness of laxative administration (...) for the management of constipation in palliative care patients, and the differential efficacy of the laxatives used to manage constipation.We searched The Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue four, 2005), MEDLINE (1966 to January 2005), EMBASE (1980 to January 2005), CANCERLIT, PUBMED, Science Citation Index, CINAHL, The Cochrane Library, SIGLE, NTIS, DHSS-DATA, Dissertation Abstracts, Index to Scientific and Technical Proceedings and NHS-NRR and reference lists

2006 Cochrane

168. Review: good evidence supports use of polyethylene glycol and tegaserod for constipation Full Text available with Trip Pro

Review: good evidence supports use of polyethylene glycol and tegaserod for constipation Review: good evidence supports use of polyethylene glycol and tegaserod for constipation | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: good evidence supports use of polyethylene glycol and tegaserod for constipation Article Text Treatment Review: good evidence supports use of polyethylene glycol and tegaserod for constipation Free Jane P Joy

2006 Evidence-Based Nursing

169. Review: intravenous and oral opioids reduce chronic non-cancer pain but are associated with high rates of constipation, nausea, and sleepiness Full Text available with Trip Pro

Review: intravenous and oral opioids reduce chronic non-cancer pain but are associated with high rates of constipation, nausea, and sleepiness Review: intravenous and oral opioids reduce chronic non-cancer pain but are associated with high rates of constipation, nausea, and sleepiness | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use (...) of constipation, nausea, and sleepiness Article Text Treatment Review: intravenous and oral opioids reduce chronic non-cancer pain but are associated with high rates of constipation, nausea, and sleepiness Free Sandra M LeFort , RN, PhD Statistics from Altmetric.com Kalso E, Edwards JE, Moore RA, et al . Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004 ; 112 : 372 –80. Q Are opioids effective and safe for reducing chronic non-cancer pain? METHODS Data sources: Medline

2006 Evidence-Based Nursing

170. Systematic review: FDA-approved prescription medications for adults with constipation

Systematic review: FDA-approved prescription medications for adults with constipation Systematic review: FDA-approved prescription medications for adults with constipation Systematic review: FDA-approved prescription medications for adults with constipation Cash B D, Lacy B E CRD summary The authors concluded that there is a lack of high-quality evidence supporting the use of lactulose and polyethylene glycol-3350 in the treatment of chronic constipation, although the data does support use (...) in acute, episodic constipation. High-quality evidence supporting the use of tegaserod was found. Potential publication and language bias, limitations of the evidence, and differences between the studies mean that the authors' conclusions should be interpreted with caution. Authors' objectives To evaluate the effectiveness of U.S. Food and Drug Administration (FDA)-approved prescription treatments for adults with constipation. Searching MEDLINE (from 1966) and EMBASE (from 1980) were searched

2006 DARE.

171. Review: soluble fibre improves overall symptoms and constipation but not abdominal pain in irritable bowel syndrome Full Text available with Trip Pro

Review: soluble fibre improves overall symptoms and constipation but not abdominal pain in irritable bowel syndrome Review: soluble fibre improves overall symptoms and constipation but not abdominal pain in irritable bowel syndrome | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: soluble fibre improves overall symptoms and constipation but not abdominal pain in irritable bowel syndrome Article Text Therapeutics Review: soluble fibre

2005 Evidence-Based Medicine

172. Is polyethylene glycol safe and effective for chronic constipation in children?

Is polyethylene glycol safe and effective for chronic constipation in children? BestBets: Is polyethylene glycol safe and effective for chronic constipation in children? Is polyethylene glycol safe and effective for chronic constipation in children? Report By: R Arora and R Srinivasan - Specialist Registrars Search checked by Bob Phillips - Section Editor Archimedes, Archives of Disease in Childhood Institution: Llandough Hospital, Cardiff, UK Date Submitted: 25th May 2005 Date Completed: 25th (...) May 2005 Last Modified: 25th May 2005 Status: Green (complete) Three Part Question In [children with chronic constipation] is [polyethylene glycol] better [in improving stool frequency and consistency while causing fewer side effects]? Clinical Scenario Chronic constipation is a frequently encountered problem in the paediatric wards and clinics. Your usual line of management has been to prescribe adequate doses of regular lactulose and use sodium picosulphate as a second line laxative or as add

2005 BestBETS

173. Prevention of constipation in the older adult population.

Prevention of constipation in the older adult population. Guidelines and Measures | Agency for Healthcare Research & Quality HHS.gov Search ahrq.gov Search ahrq.gov Menu Topics A - Z Healthcare Delivery Latest available findings on quality of and access to health care Searchable database of AHRQ Grants, Working Papers & HHS Recovery Act Projects AHRQ Projects funded by the Patient-Centered Outcomes Research Trust Fund You are here Guidelines and Measures Funding for the National Guideline

2005 Registered Nurses' Association of Ontario

174. Prevention of Constipation in the Older Adult Population

Prevention of Constipation in the Older Adult Population Nursing Best Practice Guideline Shaping the future of Nursing Revised March 2005 Prevention of Constipation in the Older Adult PopulationGreetings from Doris Grinspun Executive Director Registered Nurses’ Association of Ontario It is with great excitement that the Registered Nurses’ Association of Ontario disseminates this revised nursing best practice guideline to you. Evidence-based practice supports the excellence in service (...) , BJ Program Assistant Carrie Scott Administrative Assistant Julie Burris Administrative Assistant Keith Powell, BA, AIT Web Editor Prevention of Constipation in the Older Adult Population Registered Nurses’ Association of Ontario Nursing Best Practice Guidelines Program 111 Richmond Street West, Suite 1100 Toronto, Ontario M5H 2G4 Website: www.rnao.org/bestpracticesJean Benton, RN(EC), BScN, PHCNP , CGN(C), NCA Team Leader Primary Health Care Nurse Practitioner County of Renfrew Municipal Homes

2005 Registered Nurses' Association of Ontario

175. Does successful treatment of constipation or faecal impaction resolve lower urinary tract symptoms: a structured review of the literature. Systematic review

Does successful treatment of constipation or faecal impaction resolve lower urinary tract symptoms: a structured review of the literature. Systematic review Does successful treatment of constipation or faecal impaction resolve lower urinary tract symptoms: a structured review of the literature. Systematic review Does successful treatment of constipation or faecal impaction resolve lower urinary tract symptoms: a structured review of the literature. Systematic review Ostaszkiewicz J, Ski C (...) , Hornby L CRD summary The authors concluded that there was limited and conflicting evidence about the relationship between constipation or faecal impaction and urinary incontinence and other lower urinary tract symptoms, and that further research is required. There were limitations to this review but, overall, the authors' conclusions appear to reflect the limitations of the evidence presented. Authors' objectives To evaluate the relationship between constipation or faecal impaction and urinary

2005 DARE.

176. Diagnostic value of abdominal radiography in constipated children: a systematic review

Diagnostic value of abdominal radiography in constipated children: a systematic review Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

177. Clinical utility of diagnostic tests for constipation in adults: a systematic review

Clinical utility of diagnostic tests for constipation in adults: a systematic review Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

178. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review

Efficacy and safety of traditional medical therapies for chronic constipation: systematic review Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

179. Management of constipation in residents with dementia: sorbitol effectiveness and cost

Management of constipation in residents with dementia: sorbitol effectiveness and cost Management of constipation in residents with dementia: sorbitol effectiveness and cost Management of constipation in residents with dementia: sorbitol effectiveness and cost Volicer L, Lane P, Panke J A, Lyman P Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions (...) followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The study compared the therapeutic substitution of sorbitol for lactulose in the treatment of chronic constipation among nursing home residents with dementia. The doses ranged from 30 mL every other day to 6 mL twice daily. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population The study population comprised the residents of a dementia

2004 NHS Economic Evaluation Database.

180. What is the role of stimulant laxatives in the management of childhood constipation and soiling?. (Abstract)

What is the role of stimulant laxatives in the management of childhood constipation and soiling?. Constipation is extremely common in childhood and may lead to overflow soiling/encopresis. Standard treatment of the more severe case is to empty the bowels of impacted faeces by the use of oral or rectal laxatives and then maintain regular bowel movements by the continuation of osmotic and stimulant laxatives.The objective of the review was to determine the effect of stimulant laxative treatment (...) in children with chronic constipation who may also suffer from soiling / encopresis.The Cochrane database of randomised controlled trials was searched. Additional citations were sought by hand searching of paediatric journals and from contact with known professionals in the field.All identified randomised controlled trials (RCTs) which compare the administering of stimulant laxatives to children with either placebo or alternative treatment.No trials were found that met the selection criteria.No trials

2001 Cochrane